Pfizer

FRAGMIN

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Pfizer

Fragmin HCPCS:

J1645

HCPCS Code Descriptor:

Injection, dalteparin sodium, per 2500 iu

Category:

J Code

Fragmin NDCs:

00069-0195-02, 00069-0196-02, 00069-0253-10, 00069-0223-02, 00069-0232-01, 00069-0228-02, 00069-0206-02, 00069-0220-02, 00069-0217-02

Primary Type:

Anti-coagulant

Generic/Specialty Status:

Single-Source

Package Type:

Multiple

Route of Administration:

Subcutaneous

Fragmin CPT Codes:

Potential CPT administration codes for Fragmin can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00069-0195-02, 00069-0196-02, 00069-0253-10, 00069-0223-02, 00069-0228-02, 00069-0206-02, 00069-0220-02, 00069-0217-02

About Fragmin:

FRAGMIN is an Anti-coagulant drug manufactured by Pfizer and administered via the Subcutaneous route of administration. The J Code: J1645 is aligned to the drug FRAGMIN.

ACCESS PRICING AND MORE BY REGISTERING

J1645 Added Date:

January 1, 1997

J1645 Effective Date:

July 1, 2002

J1645 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Fragmin billing and coding information.
Our team did not identify a source for Fragmin patient assistance information. Please reach out to our team if you feel that this is a mistake.
FRAGMIN prescribing information can be found at the link below:
Information regarding FRAGMIN’s side effects can be found at MedlinePlus